World Anti-Doping Code Commentary Project

The first fully comprehensive resource for anti-doping practitioners, providing guidance along all steps of the doping control process. With topics ranging from signatory compliance to application of the sanctioning regime, the commentary will assist the anti-doping movement to achieve a more effective implementation and harmonized interpretation of the 2015 World Anti-Doping Code.

WADC Commentary Team

/WADC Commentary Team
­

About WADC Commentary Team

With the key output of an article-by-article commentary on the 2015 World Anti-Doping Code, the project is unique in its ambitious scope and nature of the research undertaken. The project team will collect and analyze anti-doping case law that interprets and applies the 2015 WADA Code, primarily those decisions published by the Court of Arbitration for Sport, as well as from various jurisdictions around the world. The goal is to create the first fully comprehensive resource for anti-doping practitioners, providing guidance along all steps of the doping control process.

The Johaug CAS award: Too harsh?

CAS 2017/A/5110, International Ski Federation (FIS) v. Therese Johaug & The Norwegian Olympic and Paralympic Committee and Confederation of Sports, August 21, 2017; CAS 2017/A/5110, Therese Johaug v. The Norwegian Olympic and Paralympic Committee and Confederation of Sports (NIF). This case involves a highly successful Norwegian skier, the multiple-time World Champion and Olympic medallist Ms. [...]

The Ademi CAS award: One substance? No source? No problem.

CAS 2016/A/4676, Arijan Ademi v. UEFA, 24 March 2017. In the Ademi award, the main issue in front of the CAS panel was whether the violation was 'not intentional', a question the panel had to resolve in absence of conclusive evidence as to how the substance entered the Athlete’s body. The award in essence asks: [...]

The Significance of Maria Sharapova’s Fault

CAS Award: CAS 2016/A/4643, Maria Sharapova v. ITF, 30 September 2016. This Court of Arbitration for Sport (“CAS”) award puts (at least for the moment)[1] an end to Maria Sharapova (or the “Player”)’s doping ordeal stemming from her admitted Use of Meldonium, a substance added to WADA’s Prohibited List less than a month before she [...]

By |November 23rd, 2016|No Significant Fault or Negligence|0 Comments

Cocaine blues: What the Paolini case suggests about “recreational” drug use under the 2015 World Anti-Doping Code

The Paolini decision, which was decided by the Union Cycliste Internationale’s (“UCI”) anti-doping tribunal (the “UCI Tribunal”) provides insight into the question of how Prohibited Substances used “recreationally” could be treated under the 2015 World Anti-Doping Code (the “WADC”). “Recreational” drug use was the subject of much debate among stakeholders during the WADC’s 2015 review [...]

Meldonium and Moral Fault: Five Lessons Learned from the Sharapova ITF Tribunal Decision

In Fall 2015, WADA announced its decision to add the anti-ischemic drug “Meldonium” to its Prohibited List with effect on 1 January 2016, after the Monitoring Program and observation period 2015 revealed “evidence of its use by athletes with the intention of enhancing performance” (Explanatory Notice to the 2016 List). Few observers could have predicted [...]

Talk is Cheap: The Daiders CAS Award on the Evidence Needed for a Contaminated Supplement Defense

CAS Award: CAS 2014/A/3615, WADA v. Lauris Daiders, Jànis Daiders, and FIM, January 30, 2015 While the fact pattern in this case – the unexplained presence of a Prohibited Substance allegedly attributable to supplement contamination – is not out of the ordinary, the thoroughness of the legal discussion undertaken by the CAS panel does stand [...]

The ISSF v. WADA CAS Award: Another Therapeutic Use Exemption Request for Beta Blockers Shot Down

CAS Award: CAS 2013/A/3437, International Shooting Sport Federation v. WADA,  December 18, 2014. The granting of Therapeutic Use Exemptions (“TUE”) is an important aspect of an Anti-Doping Organization’s daily activities. It is also the only way for Athletes to receive medical treatment while staying active in competitive sport when they are obliged, for therapeutic reasons [...]

By |August 10th, 2015|Therapeutic Use Exemptions|0 Comments

The Stewart CAS Award: “Paperwork” Violations and Principles Surrounding “Retrospective” Therapeutic Use Exemptions

CAS Award: CAS 2014/A/3876, Stewart v. FIM, April 27, 2015. FACTS James Stewart, a professional motocross and supercross rider, had been regularly taking the medication “Adderall” since 2012,[1] when he underwent an In-Competition Doping Control test on 12 April at the 2014 AMA Supercross FIM World Championship.[2] In May 2014, an analysis of the rider’s [...]

The Lallukka CAS Award: The End of an Unsettled Era for Human Growth Hormone Cases?

CAS Award: WADA v. Lallukka, CAS 2014/A/3488, November 20, 2014 FACTS In September 2011, the Finnish cross-country skier Juha Lallukka (the “skier”), a National-Level Athlete affiliated with the Finnish Ski Association, was subjected to an Out-of-Competition test. The analysis returned an Adverse Analytical Finding for recombinant human Growth Hormone (“rhGH”, a synthetic form of exogenously [...]

Biological passports and the 2015 Code: Will four-year bans for blood doping become the new norm?

Download the Bekele Blog Post HERE CAS Award: Alemitu Bekele Degfa v. Turkish Athletics Federation & IAAF, CAS 2013/A/3080, March 14, 2014. In this award, recently published in the CAS bulletin, Alemitu Bekele Degfa – a long-distance runner of Turkish Nationality and Ethiopian origin – was found to have committed an anti-doping violation with aggravating circumstances. [...]

By |February 3rd, 2015|Intentional violations|0 Comments